ARCHIVES

Centocor Withdraws Yondelis After FDA Calls for New Study

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984

Hait To Take Office As AACR President, DuBois Is President-Elect.

March 30, 2007

Fruit, Vegetables Don’t Prevent Protect Against Breast Cancer

February 25, 2005

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006